The Latest Breaking News from Cardiomyopathy

Mavacamten would be used to treat obstructive hypertrophic cardiomyopathy, with about 7,000 people expected to benefit.

Coronation Street actress Alexandra Mardell, who played Emma Brooker in the soap, made a touching tribute to her father when she tied the knot with husband Joe Parker

'Sports mad' McLaren High School pupil from Doune died of a heart condition in 2008.

Scientists from the University of Utah Health have corrected abnormal heart rhythms in mice by restoring healthy levels of a protein that heart cells require to connect with one another. Read further on Dynamite News:

The family of a Doune teenager who tragically died of a rare heart condition have met with Stirling’s MSP. Evelyn Tweed MSP met with Morag and Gilbert Ferrier to discuss the debate on cardiomyopathy and hopes for the future. Earlier this year, Ms T

The family of a Doune teenager who tragically died of a rare heart condition have been praised at Scottish Parliament for their awareness raising and fundraising efforts. Callum Ferrier, described as fit and “sports-mad”, was aged just 16 when his d

CHICAGO — Te’Jaan Ali was playing basketball in a school gym on the South Side of Chicago when he started feeling hot. The heat in the gym — which didn’t have air conditioning — was likely just as bad as the sweltering temperatures outside, which reached 90 degrees on July…

The true story of a male nurse who murdered up to hundreds of patients in US hospitals by secretly administering drug overdoses is brought to the screen by an all-star team of filmmakers in "The Good Nurse". Based on a book of the same name, "The Good Nurse" centers around…

Bristol Myers Squibb (NYSE:BMY) and 2seventy bio (NASDAQ:TSVT) announced positive topline results from KarMMa-3, a Phase 3 study evaluating Abecma (idecabtagene vicleucel) compared to standard combination regimens in adults with multiple myeloma that is relapsed and refractory. Bristol Myers shares traded in a range of $73.95 to $75.32 on a day volume…

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ:MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns. MediWound shares traded in a range of $1.6 to $1.76 on a day…

In 2018, the FDA began investigating whether the increasing popularity of grain-free dog foods had led to a sudden rise in a potentially fatal heart disease in dogs